Plasma Service Europe
Plasma Service Europe GmbH operates 14 plasma donation centers across 13 German cities, collecting blood plasma via plasmapheresis for parent company Biotest AG's pharmaceutical manufacturing pipeline, serving over 187,000 registered donors and supplying raw material for plasma-derived medicines treating immunodeficiencies, hemophilia, and critical care patients.
- Company typePrivate
- Founded2001
- HeadquartersRostock, Germany
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Plasma Service Europe does
Plasma Service Europe GmbH is a German plasma collection company founded in 2001 and headquartered in Rostock, operating 14 plasma donation centers across 13 German cities including Aachen, Darmstadt, Dortmund, Halle, Hannover, Karlsruhe, Köln (two sites), Magdeburg, Merseburg, Münster, Nordhausen, Rostock, and Wuppertal. The company is a wholly-owned subsidiary of Biotest AG (Biotest GmbH & Co. KGaA), a Dreieich-based pharmaceutical manufacturer specializing in plasma-derived medicines, which provides the vertical integration from raw plasma collection through to finished pharmaceutical products. The company employs 501-1000 staff and has built a registered donor base of over 187,000 individuals.
The core service is plasmapheresis: donors visit physical centers where plasma is extracted via apheresis technology, frozen at approximately -30°C, and shipped to Biotest for processing into plasma-derived medicines used in treating immunodeficiencies, hemophilia, and emergency/critical care indications. Each donor can donate up to 60 times per year due to plasma regeneration capacity. The company is IQPP (International Quality Plasma Program) certified, holding enhanced quality standards required for the German and EU blood products regulatory environment. Digital engagement is provided through the PlasmApp mobile application (iOS and Android), which supports appointment booking, disruption notifications, and access to bonus campaigns including High Five, Hammer, and Knack 75 incentive programs.
The revenue model is a B2B off-take arrangement with parent Biotest AG: the company pays per-donation compensation to individual donors, and Biotest pays for the collected plasma that feeds its pharmaceutical manufacturing pipeline. GTM is direct-to-consumer at the donor level, with marketing conducted through the company website, social media (Facebook, Instagram, YouTube), email newsletters, local community events, influencer partnerships (Gina Rühl), patient advocacy organizations (dsai e.V., IGH), and local sports/cinema/pharmacy referral partnerships. The October 2025 DKMS partnership added bone marrow donor registration to all 14 centers, broadening the platform beyond plasma collection.
Plasma Service Europe firmographics
Firmographics- Name
- Plasma Service Europe
- Legal name
- Plasma Service Europe GmbH
- Website
- https://plasmaservice.de
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Plasma Service Europe GmbH operates 14 plasma donation centers across 13 German cities, collecting blood plasma via plasmapheresis for parent company Biotest AG's pharmaceutical manufacturing pipeline, serving over 187,000 registered donors and supplying raw material for plasma-derived medicines treating immunodeficiencies, hemophilia, and critical care patients.
- Ownership category
- akta.pro rank
Plasma Service Europe industry classification
Industry- Product category
- Plasma Collection Services
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
- akta.pro secondary industries
- Plasma-Derived & Blood Products Distributors (HLAIAJAJ), Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)
Keywords
Where Plasma Service Europe is headquartered
LocationHeadquarters
- HQ city
- Rostock
- HQ country
- Germany
- HQ region
- Europe
Offices14 records
Markets served
Plasma Service Europe business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Plasma Donation Services: The company operates plasma donation centers where individuals donate plasma in exchange for compensation. Plasma is collected, processed, and supplied to pharmaceutical companies for the production of plasma-derived medicines. Revenue is generated through compensation payments to donors, with the company receiving payment from pharmaceutical manufacturers for the collected plasma.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard plasma donation compensation |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels10 records
Plasma Service Europe product offering
Product offeringCore offering
Plasma Service Europe GmbH operates 14 plasma donation centers across Germany where healthy individuals donate blood plasma through plasmapheresis in exchange for per-donation compensation and free health screenings. The collected plasma is frozen and supplied to pharmaceutical manufacturer Biotest AG (the parent company) for processing into plasma-derived medicines for patients with immunodeficiencies, hemophilia, and emergency/critical care needs. Donors are supported by the PlasmApp mobile application for self-service appointment booking, push notifications, and access to bonus campaigns.
Product overview
Plasma Service Europe operates a network of 14 plasma donation centers across Germany, offering plasmapheresis services where donors can donate plasma for the production of life-saving medications. The company provides the PlasmApp mobile application for donors to manage appointments and receive communications. The centers are located in major German cities including Aachen, Darmstadt, Dortmund, Halle, Hannover, Karlsruhe, Köln (two locations), Magdeburg, Merseburg, Münster, Nordhausen, Rostock, and Wuppertal. Founded in 2001, the company is a subsidiary of Biotest AG and has registered over 187,000 donors.
Differentiator
Problem solved
Functional benefit
Brands
- PlasmApp: Mobile application for plasma donors to manage appointments, receive notifications, and access donor services.
Products and services
- Plasma Donation Centers (Plasmazentren) Network of 14 owned plasma donation centers across 13 German cities (Aachen, Darmstadt, Dortmund, Halle, Hannover, Karlsruhe, Köln x2, Magdeburg, Merseburg, Münster, Nordhausen, Rostock, Wuppertal). Each center performs plasmapheresis, freezes plasma at approximately -30°C, and provides donors with per-donation compensation (Aufwandsentschädigung), free health screenings, and modern amenities. The collected plasma is supplied to parent company Biotest AG for fractionation into plasma-derived medicines.
- PlasmApp Proprietary mobile application for iOS and Android that enables registered plasma donors to self-book donation appointments, receive push notifications about schedule changes and disruptions, and access information about bonus campaigns (High Five, Hammer, Knack 75). Available for free in the Apple App Store and Google Play Store.
Quantifiable outcome
- 187,000+ registered plasma donors have donated at company centers
- +4 more outcomes
Companies that use Plasma Service Europe
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Plasma Service Europe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Plasma Service Europe partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- DKMS (Deutsche Knochenmarkspenderdatei)coreSince October 20, 2025, all 14 plasma donation centers offer DKMS bone marrow registration. Donors can register as potential stem cell donors with a simple cheek swab during plasma donation visits. Partnership addresses blood cancer patients (approximately 13,500 diagnosed in Germany in 2022 per Robert Koch Institut).
- Biotest AGcoreParent company Biotest AG (Biotest GmbH & Co. KGaA) based in Dreieich. Plasma Service Europe is an expanding subsidiary founded in 2001. Biotest manufactures plasma-derived medicines from collected plasma. Information events held at Biotest headquarters with CEO Dr. Jörg Schüttrumpf participation.
- Flugkraft (Dortmund)minorLocal partnership for donor engagement in Dortmund, offering additional benefits or recognition for plasma donors.
- Lichtspiel und Kunsttheater Schauburg (Dortmund)minorPartnership with independent cinema Schauburg in Dortmund, providing donor perks or visibility for plasma donation.
- Fitness & Co. (Dortmund)minorFitness studio partnership offering donor benefits for Plasma Service Europe donors in Dortmund.
- V.f.B. Langendreerholz 1914 e.V. (Dortmund)minorLocal sports club partnership in Dortmund for community engagement and donor referral.
- Das Dortmunder U (Dortmund)minorPartnership with Zentrum für Kunst und Kreativität (art and creativity center) for cultural engagement in Dortmund.
- Kinderglück Dortmund e.V. (Dortmund)minorPartnership with children's charity network for social impact and community engagement.
- SV Halle LionsminorLocal sports club partnership in Halle for community engagement.
- Hallescher FC e.V.minorPartnership with Hallescher FC football club for regional visibility and donor engagement in Halle.
- Barmer GEKminorHealth insurer partnership covering Halle, Magdeburg, Nordhausen, and Rostock regions for health-conscious donor recruitment.
- Birken Apotheke (Köln)minorLocal pharmacy partnership in Köln for health-related referral and community engagement.
- Claudius Therme (Köln)minorWellness facility partnership in Köln offering donor relaxation benefits.
- Kölner HaieminorPartnership with Köln ice hockey team (PENNY DEL) for regional sports sponsorship and donor engagement.
- AOK PLUSminorStatutory health insurance partnership in Nordhausen region for health-conscious donor recruitment.
- dsai e.V. (Patientenorganisation angeborene Immundefekte)corePatient organization for primary immunodeficiencies. Representatives Dr. Gerd Klock and Jan Dietz participate in center events and share testimonials about importance of plasma donations. Featured at Darmstadt and Karlsruhe openings.
- IGH (Interessengemeinschaft Hämophiler)corePatient organization for hemophilia. Patient representative Alexander Heise volunteers with IGH and educates about living with hemophilia through social media.
- Aktion MenschminorSocial charity organization partnership. Regular lottery giveaways (Jahreslos - annual lottery tickets) for donor engagement campaigns. First Good Deed 2026 campaign featured 14 annual lottery tickets as prizes.
Scale indicators9 records
Recent moves10 records
Expansion highlights5 records
Plasma Service Europe competitors and assessment
Company assessmentDirect peers
- Haema AG: Haema AG is one of the largest plasma collection operators in Germany, also owned by Grifols. It directly competes with Plasma Service Europe in the same German market for plasma donors using a similar center-based, donor-compensated model.
- Octapharma Plasma: Octapharma Plasma operates a global network of plasma donation centers and is owned by Octapharma AG (Switzerland). It competes with PSE for plasma donors and operates a comparable center-based plasmapheresis business model.
- CSL Plasma: CSL Plasma is one of the world's largest plasma collection networks, owned by CSL Limited (Australia). It operates a nearly identical business model of compensated plasma donation centers and competes with PSE globally including in Germany.
- BioLife Plasma Services: BioLife Plasma Services operates a global network of plasma donation centers as a subsidiary of Takeda Pharmaceutical. It is a direct competitor using the same center-based plasmapheresis and donor compensation model.
- Kedrion Biopharma: Kedrion Biopharma is an Italian plasma-derived therapy company that operates plasma collection centers across Europe and the US, directly competing with PSE in the European plasma supply chain.
Broad incumbents
- Biotest AG: Biotest AG is the parent company of Plasma Service Europe and one of Europe's leading manufacturers of plasma-derived therapies. It is comparable as the downstream integrated pharmaceutical manufacturer that PSE supplies.
- Grifols: Grifols is the ultimate parent of Biotest AG (and thus PSE) and a global leader in plasma-derived therapies with the largest plasma collection network worldwide. It represents the broader incumbent player in the integrated plasma value chain.
Regional players
- Sanquin Plasma Products: Sanquin is the Dutch national blood supply organization and operates plasma fractionation and collection activities. It is comparable as a European nonprofit/regional plasma collector serving the same therapy market.
Others
- Cerus Corporation: Cerus Corporation provides pathogen reduction technologies used in plasma and blood product safety. It is comparable as an enabling technology supplier in the plasma value chain serving collection centers like PSE.
- Haemonetics Corporation: Haemonetics provides plasma collection technology, including apheresis devices and software used by plasma centers globally. It is comparable as an equipment and technology supplier serving PSE's operational infrastructure.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Plasma Service Europe social profiles
Digital presencePlasma Service Europe compliance and trust
Trust signalCompliance1 record
Plasma Service Europe financial estimates
Financial estimateRevenue estimate
Valuation estimate
Plasma Service Europe leadership team
Management profileNumber of profiles
Profiles2 records
Plasma Service Europe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Plasma Service Europe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Plasma Service Europe
What does Plasma Service Europe do?
Plasma Service Europe GmbH operates 14 plasma donation centers across Germany where healthy individuals donate blood plasma through plasmapheresis in exchange for per-donation compensation and free health screenings. The collected plasma is frozen and supplied to pharmaceutical manufacturer Biotest AG (the parent company) for processing into plasma-derived medicines for patients with immunodeficiencies, hemophilia, and emergency/critical care needs. Donors are supported by the PlasmApp mobile application for self-service appointment booking, push notifications, and access to bonus campaigns.
Is Plasma Service Europe a public or private company?
Plasma Service Europe is a private company. It is classified as corporate owned and is currently operating.
When was Plasma Service Europe founded?
Plasma Service Europe was founded in 2001. It employs 501 to 1,000 people.
Where is Plasma Service Europe based?
Plasma Service Europe is headquartered in Rostock, Germany, in the Europe region.
How does Plasma Service Europe make money?
One revenue line is on record: plasma Donation Services.
Who are Plasma Service Europe's main competitors?
Direct peers on record are Haema AG, Octapharma Plasma, CSL Plasma, BioLife Plasma Services and Kedrion Biopharma. Broad incumbents are Biotest AG and Grifols. Sanquin Plasma Products is listed as a regional player. Others are Cerus Corporation and Haemonetics Corporation.
Does Plasma Service Europe have an API?
No public API is recorded for Plasma Service Europe.
What industry is Plasma Service Europe in?
Plasma Service Europe's product category is Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAIAJAJ, Plasma-Derived & Blood Products Distributors. Its NAICS code is 621991.